Skip to main content
An official website of the United States government

Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Name, Email, Phone Room Group(s)/Office
Heckman-Stoddard, Brandy, Ph.D., M.P.H.
brandy.heckman-stoddard@nih.gov
240-276-7048
5E334 Chief | Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials
Lee, Beverly
beverly.lee@nih.gov
240-614-3425
5E532 Program Officer | Community Oncology and Prevention Trials
Lee, Cecilia, Dr.P.H., RN
cecilia.lee@nih.gov
240-276-7152
5E516 Nurse Consultant | Community Oncology and Prevention Trials
Maxwell, Pamela
pamela.maxwell@nih.gov
240-276-7081
5E434 Program Specialist | Community Oncology and Prevention Trials
McCarty, Larae
larae.mccarty@nih.gov
240-276-5777
5E322 Program Specialist | Community Oncology and Prevention Trials
Early Detection
Parker, Bernard, M.D., FACP
bernard.parker@nih.gov
240-276-5533
5E448 Program Officer | Community Oncology and Prevention Trials
Streck, Brennan, Ph.D., RN, M.P.H.
brennan.streck@nih.gov
240-276-7050
5E430 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
White, Vanessa A., M.P.H.
vanessa.white@nih.gov
240-276-6163
5E524 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
Whitman, Cynthia, B.S. [C]
cynthia.whitman@nih.gov
240-276-7068
5E524 Contractor | Community Oncology and Prevention Trials

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Prigerson, Holly Gwen

Weill Medical Coll Of Cornell Univ
United States

Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) 5R35CA197730-10 Brennan Streck, Ph.D., RN, M.P.H.
Rini, Christine

Northwestern University At Chicago
United States

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial 5R01CA271220-03 Brennan Streck, Ph.D., RN, M.P.H.
Ross, Stephen

New York University School Of Medicine
United States

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-03 Rachel Altshuler, Ph.D.
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-03 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity 5R01CA230512-05 Rachel Altshuler, Ph.D.
Schenker, Yael

University Of Pittsburgh At Pittsburgh
United States

Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial 5R01CA235730-06 Brennan Streck, Ph.D., RN, M.P.H.
Shelby, Rebecca A

Duke University
United States

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis 5R01CA249959-05 Brennan Streck, Ph.D., RN, M.P.H.
Shen, Chan

Pennsylvania State Univ Hershey Med Ctr
United States

The effects of hydrocodone rescheduling on pain management of older lung cancer patients 1R21CA277849-01 Rachel Altshuler, Ph.D.
Smith, Ellen Mary Lavoie

University Of Alabama At Birmingham
United States

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study 5R01CA235726-07 Brennan Streck, Ph.D., RN, M.P.H.
Somers, Tamara J

Duke University
United States

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial 5R01CA237892-05 Brennan Streck, Ph.D., RN, M.P.H.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 Rachel Altshuler, Ph.D.
Tamrazi, Benita

Children'S Hospital Of Los Angeles
United States

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors 5R21CA262978-02 Rachel Altshuler, Ph.D.
Tighiouart, Mourad

Cedars-Sinai Medical Center
United States

Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials 3U01CA232859-05S1 Rachel Altshuler, Ph.D.